1. National Institute for Health and Care Excellence . Falls in older people: assessing risk and prevention. Clinical guideline [CG161], https://www.nice.org.uk/guidance/cg161 (2013, accessed 4 November 2020).
Google Scholar2. Kersten, H, Wyller, TB. Anticholinergic drug burden in older people’s brain – how well is it measured? J Basic Clin Pharm 2014; 114: 151–159.
Google Scholar | Crossref3. Kouladjian, O’Donnell L, Gnjidic, D, Nahas, R, et al. Anticholinergic burden: considerations for older adults. J Pharm Prac Res 2017; 47: 67–77.
Google Scholar | Crossref4. Gerretsen, P, Pollock, BG. Cognitive risks of anticholinergics in the elderly. Aging Health 2013; 9: 159–166.
Google Scholar | Crossref5. Lampela, P, Lavikainen, P, Garcia-Horsman, JA, et al. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study. Drugs Aging 2013; 30: 321–330.
Google Scholar | Crossref | Medline | ISI6. Merchant, RA, Li, B, Yap, KB, et al. Use of drugs with anticholinergic effects and cognitive impairment in community-living older persons. Age Ageing 2008; 38: 105–108.
Google Scholar | Crossref | Medline7. Sittironnarit, G, Ames, D, Bush, AI, et al. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dement Geriat Cogn Disord 2011; 31: 173–178.
Google Scholar | Crossref | Medline | ISI8. Cardwell, K, Hughes, CM, Ryan, C. The association between anticholinergic medication burden and health related outcomes in the ‘oldest old’: a systematic review of the literature. Drugs Aging 2015; 32: 835–848.
Google Scholar | Crossref | Medline | ISI9. Salahudeen, MS, Duffull, SB, Nishtala, PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr 2015; 15: 31.
Google Scholar | Crossref | Medline | ISI10. Stewart, C, Yrjana, K, Kishor, M, et al. Anticholinergic burden measures predict older people’s physical function and quality of life: a systematic review. J Am Med Dir Assoc 2020; 22: 56–64.
Google Scholar | Crossref | Medline11. Graves-Morris, K, Stewart, C, Soiza, RL, et al. The prognostic value of anticholinergic burden measures in relation to mortality in older individuals: a systematic review and meta-analysis. Front Pharmacol 2020; 11: 570.
Google Scholar | Crossref | Medline12. Geersing, G-J, Bouwmeester, W, Zuithoff, P, et al. Search filters for finding prognostic and diagnostic prediction studies in Medline to enhance systematic reviews. PLoS One 2012; 7: e32844.
Google Scholar | Crossref | Medline13. Welsh, TJ, van der Wardt, V, Ojo, G, et al. Anticholinergic drug burden tools/scales and adverse outcomes in different clinical settings: a systematic review of reviews. Drugs Aging 2018; 35: 523–538.
Google Scholar | Crossref | Medline14. Green, AR, Reifler, LM, Bayliss, EA, et al. Drugs contributing to anticholinergic burden and risk of fall or fall-related injury among older adults with mild cognitive impairment, dementia and multiple chronic conditions: a retrospective cohort study. Drugs Aging 2019; 36: 289–297.
Google Scholar | Crossref | Medline15. Hwan, S, Jun, K, Ah, Y-M, et al. Impact of anticholinergic burden on emergency department visits among older adults in Korea: a national population cohort study. Arch Gerontol Geriatr 2019; 85: 103912.
Google Scholar | Crossref | Medline16. Landi, F, Dell’Aquila, G, Collamati, A, et al. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. J Am Med Dir Assoc 2014; 15: 825–829.
Google Scholar | Crossref | Medline17. Richardson, K, Bennett, K, Maidment, ID, et al. Use of medications with anticholinergic activity and self-reported injurious falls in older community-dwelling adults. J Am Geriatr Soc 2015; 63: 1561–1569.
Google Scholar | Crossref | Medline18. Squires, P, Pahor, M, Manini, TM, et al. Impact of anticholinergic medication burden on mobility and falls in the Lifestyle Interventions for Elders (LIFE) study. J Clin Med 2020; 9: 2989.
Google Scholar | Crossref | Medline19. Suehs, BT, Caplan, EO, Hayden, J, et al. The relationship between anticholinergic exposure and falls, fractures, and mortality in patients with overactive bladder. Drugs Aging 2019; 36: 957–967.
Google Scholar | Crossref | Medline20. Tan, MP, Tan, GJ, Mat, S, et al. Use of medications with anticholinergic properties and the long-term risk of hospitalization for falls and fractures in the EPIC-Norfolk Longitudinal Cohort Study. Drugs Aging 2020; 37: 105–114.
Google Scholar | Crossref | Medline21. Zia, A, Kamaruzzaman, S, Myint, PK, et al. Anticholinergic burden is associated with recurrent and injurious falls in older individuals. Maturitas 2016; 84: 32–37.
Google Scholar | Crossref | Medline22. Reinold, J, Schäfer, W, Christianson, L, et al. Anticholinergic burden and fractures: a systematic review with methodological appraisal. Drugs Aging 2020; 37: 885–897.
Google Scholar | Crossref | Medline23. Crispo, JAG, Willis, AW, Thibault, DP, et al. Associations between anticholinergic burden and adverse health outcomes in Parkinson disease. PLoS One 2016; 11: e0150621.
Google Scholar | Crossref | Medline24. Stewart, C, Yrjana, K, Kishor, M, et al. Anticholinergic burden measures predict older people’s physical function and quality of life: a systematic review. J Am Med Dir Assoc. Epub ahead of print 21 July 2020. DOI: 10.1016/j.jamda.2020.05.065.
Google Scholar | Crossref25. Sousa, LM, Marques-Vieira, CM, Caldevilla, MN, et al. Risk for falls among community-dwelling older people: systematic literature review. Rev Gaucha Enferm 2017; 37: e55030.
Google Scholar | Medline26. Dhalwani, NN, Fahami, R, Sathanapally, H, et al. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open 2017; 7: e016358.
Google Scholar | Crossref | Medline27. Zaninotto, P, Huang, YT, Di Gessa, G, et al. Polypharmacy is a risk factor for hospital admission due to a fall: evidence from the English Longitudinal Study of Ageing. BMC Public Health 2020; 20: 1–7.
Google Scholar | Crossref | Medline28. Seppala, LJ, Wermelink, AMAT, de Vries, M, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc 2018; 19: 371.e11–371.e17.
Google Scholar29. de Vries, M, Seppala, LJ, Daams, JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: I. Cardiovascular drugs. J Am Med Dir Assoc 2018; 19: 371.e1–371.e9.
Google Scholar | Crossref